MILLENIUM MEDICAL MARSEILLE : revenue, balance sheet and financial ratios

MILLENIUM MEDICAL MARSEILLE is a French company founded 25 years ago, specialized in the sector Location et location-bail d'autres biens personnels et domestiques. Based in BOUC-BEL-AIR (13320), this company of category PME shows in 2024 a revenue of 118 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - MILLENIUM MEDICAL MARSEILLE (SIREN 431891076)
Indicator 2024 2023 2022 2019 2018 2017 2016
Revenue 118 400 € 122 400 € 110 400 € 96 000 € N/C 369 147 € 369 147 €
Net income 59 237 € 435 382 € 426 680 € -265 494 € 8 800 173 € -278 020 € 11 156 €
EBITDA -15 777 € -17 209 € -10 564 € -130 959 € N/C 5 873 € 38 670 €
Net margin 50.0% 355.7% 386.5% -276.6% N/C -75.3% 3.0%

Revenue and income statement

In 2024, MILLENIUM MEDICAL MARSEILLE achieves revenue of 118 k€. Revenue is declining over the period 2016-2024 (CAGR: -13.3%). Slight decline of -3% vs 2023. After deducting consumption (0 €), gross margin stands at 118 k€, i.e. a rate of 100%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches -16 k€, representing -13.3% of revenue. Negative EBITDA means operations do not cover current expenses: concerning situation. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 59 k€, i.e. 50.0% of revenue. This profit can be retained or distributed to shareholders.

Revenue (2024) ?
Revenue
Definition
Total amount of sales of goods and services made by the company.
Formula
Sales of goods + Sold production

118 400 €

Gross margin (2024) ?
Gross margin
Definition
Difference between revenue and cost of goods sold.
Formula
Revenue - Cost of goods consumed

118 400 €

EBITDA (2024) ?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity

-15 777 €

EBIT (2024) ?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals

-131 715 €

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

59 237 €

EBITDA margin (2024) ?
EBITDA margin
Definition
Measures the company's operating profitability.
Formula
(EBE / CA) x 100
Interpretation
> 10% : Good profitability
5-10% : Average
< 5% : Low

-13.3%

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 4%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 94%. This high autonomy means the company finances most of its assets through equity, a sign of strength. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 1.6 years of cash flow to repay all financial debt. This short period demonstrates excellent debt sustainability. Cash flow represents 148.1% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment. This high level provides strong self-financing capacity.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

3.893%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

94.36%

Cash flow / Revenue (2024) ?
Cash flow / Revenue
Definition
Self-financing capacity relative to revenue.
Formula
(CAF / CA) x 100
Interpretation
The higher the ratio, the more cash the company generates

148.11%

Repayment capacity (2024) ?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent
3-5 years : Fair
> 5 years : Warning

1.614

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

69.0%

Solvency indicators evolution
MILLENIUM MEDICAL MARSEILLE

Sector positioning

Debt ratio
3.89 2024
2022
2023
2024
Q1: 0.0
Med: 9.81
Q3: 79.47
Good

In 2024, the debt ratio of MILLENIUM MEDICAL MARSEILLE (3.89) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.

Financial autonomy
94.36% 2024
2022
2023
2024
Q1: 5.79%
Med: 33.76%
Q3: 60.35%
Excellent +9 pts over 3 years

In 2024, the financial autonomy of MILLENIUM MEDICAL MARSEILLE (94.4%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.

Repayment capacity
1.61 years 2024
2022
2023
2024
Q1: 0.0 years
Med: 0.07 years
Q3: 1.57 years
Average +50 pts over 3 years

In 2024, the repayment capacity of MILLENIUM MEDICAL MARSEILLE (1.61) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 2246.86. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

2246.859

Interest coverage (2024) ?
Interest coverage
Definition
Ability to cover interest charges with operating income.
Formula
EBIT / Interest expenses
Interpretation
> 3 : Comfortable
1.5-3 : Acceptable
< 1.5 : Risk

-10.82

Liquidity indicators evolution
MILLENIUM MEDICAL MARSEILLE

Sector positioning

Liquidity ratio
2246.86 2024
2022
2023
2024
Q1: 106.8
Med: 176.44
Q3: 303.96
Excellent

In 2024, the liquidity ratio of MILLENIUM MEDICAL MARSEILLE (2246.86) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.

Interest coverage
-10.82x 2024
2022
2023
2024
Q1: 0.0x
Med: 0.0x
Q3: 2.31x
Average

In 2024, the interest coverage of MILLENIUM MEDICAL MARSEILLE (-10.8x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 36 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 0 days. The gap of 36 days means the company finances its customers for over a month before being paid relative to supplier payments. This weighs on cash flow. WCR is negative (-283 days): operations structurally generate cash. Notable WCR improvement over the period (-143%), freeing up cash.

Operating WCR (2024) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

-93 025 €

Customer credit (2024) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

36 j

Supplier credit (2024) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2024) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR in days of revenue (2024) ?
WCR in days of revenue
Definition
Expresses working capital requirement in days of revenue.
Formula
(Operating WCR / Revenue) x 360
Interpretation
The fewer days, the better the working capital management

-283 j

WCR and payment terms evolution
MILLENIUM MEDICAL MARSEILLE

Positioning of MILLENIUM MEDICAL MARSEILLE in its sector

Comparison with sector Location et location-bail d'autres biens personnels et domestiques

Valuation estimate

Based on 69 transactions of similar company sales (all years), the value of MILLENIUM MEDICAL MARSEILLE is estimated at 123 859 € (range 51 548€ - 334 436€). The price/revenue ratio is 0.40x (conservative valuation). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.

Estimated enterprise value 2024
69 tx
51k€ 123k€ 334k€
123 859 € Range: 51 548€ - 334 436€
NAF 5 all-time

Valuation detail by method

Ajustez les pondérations selon votre analyse

Revenue Multiple 30%
118 400 € × 0.40x
Estimation 47 702 €
23 802€ - 74 406€
Net Income Multiple 20%
59 237 € × 4.0x
Estimation 238 096 €
93 168€ - 724 483€

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 69 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Location et location-bail d'autres biens personnels et domestiques)

Compare MILLENIUM MEDICAL MARSEILLE with other companies in the same sector:

Voir toutes les statistiques du secteur Location et location-bail d'autres biens personnels et domestiques

Frequently asked questions about MILLENIUM MEDICAL MARSEILLE

What is the revenue of MILLENIUM MEDICAL MARSEILLE ?

The revenue of MILLENIUM MEDICAL MARSEILLE in 2024 is 118 k€.

Is MILLENIUM MEDICAL MARSEILLE profitable?

Yes, MILLENIUM MEDICAL MARSEILLE generated a net profit of 59 k€ in 2024.

Where is the headquarters of MILLENIUM MEDICAL MARSEILLE ?

The headquarters of MILLENIUM MEDICAL MARSEILLE is located in BOUC-BEL-AIR (13320), in the department Bouches-du-Rhone.

Where to find the tax return of MILLENIUM MEDICAL MARSEILLE ?

The tax return of MILLENIUM MEDICAL MARSEILLE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does MILLENIUM MEDICAL MARSEILLE operate?

MILLENIUM MEDICAL MARSEILLE operates in the sector Location et location-bail d'autres biens personnels et domestiques (NAF code 77.29Z). See the 'Sector positioning' section above to compare the company with its competitors.